there have been several large-scale recall,from nov.2009 to July 2010,in Johnson&Johnson,recently,April 30, 2010, Johnson & Johnson subsidiary McNeil Corporation to products the quality of the ground did not meet the standard completely, announced the recall of 12 countries and regions with a cold fever infant drug Tainuo Lin , Merrill Lynch, allergy medication Zyrtec, and KTM and so can be more than 40 kinds of non-prescription drugs; July 8, 2010, McNeil has announced the recall of 21 batches of children and adults with Tylenol, allergy medicationKTM and analgesia Merrill Lynch.

But in several large-scale recall,exclude China market.

A spokesman for Johnson & Johnson China News, Shanghai Johnson & Johnson Co., Ltd. director of government affairs and communications told time weekly reporters,"McNeil said in the United States, Fiji, Guatemala and other markets The recalled 21 kinds of non-prescription drugs , and did not enter the Chinese market. Chinese consumers are using non-prescription drugs were from Shanghai Johnson & Johnson plant in, fully in line with the Chinese medicines good manufacturing practices (GMP), quality of safe, reliable, does not exist Foreign recall problems. "

But Wang Heng, general manager from Beijing Best Power Marketing pointed out that "Johnson did to China and other countries adopted a double standard.
Wang Heng, said many of the world raw material sourcing from China, almost raw material, production process is also similar.
 

As for whether the issue of bribery, Wang Heng replys, the current tender system which provides domestic only, once related to bribery, two years are not allowed to participate in the procurement bidding, but many of Johnson & Johnson products is OTC, taking the retail channels, will not participate in bidding, in fact, there would be no punishment,at the most, prescription drugs will be limited in the hospital.